Literature DB >> 1220761

Increase in the gastrointestinal absorption and in tissue storage of cyclophosphamide in L-1210 leukaemic mice at an advanced stage of the disease.

J G Lavigne, A Barry, C D'Auteuil, J M Delâge.   

Abstract

BDF1 mice were inoculated with 10(6) leukaemic cells and, together with control mice, were given a single oral dose of cyclophosphamide-14C of 100 mg/kg body weight. In the leukaemic mice we observed an increased 14C concentration in the plasma, bone marrow, liver, lungs, spleen, kidney and particularly fat where the level was 2-4 times higher than in control mice. Conversely, during the same period, significantly less 14C was detected in the stomach and small intestine of the leukaemic mice. These results were obtained 6 days after tumour transplantation (median survival time 7.7 days) whereas no differences were observed when the studies were carried out 4 days after tumour transplantation. These findings indicate an increase in the gastrointestinal absorption and in the tissue storage fo cyclophosphamide in L-1210 leukaemic mice at an advanced stage of the disease.

Entities:  

Mesh:

Year:  1975        PMID: 1220761      PMCID: PMC2025034          DOI: 10.1038/bjc.1975.283

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

Review 1.  The clinical pharmacology of antineoplastic agents (first of two parts).

Authors:  B A Chabner; C E Myers; C N Coleman; D G Johns
Journal:  N Engl J Med       Date:  1975-05-22       Impact factor: 91.245

2.  Activity of cyclophosphamide and 1-methylnitrosourea on Ehrlich carcinoma transplanted in different sites. Correlation between drug level and tumor inhibition.

Authors:  A Bossi; T Colombo; M G Donelli; S Garattini
Journal:  Biochem Pharmacol       Date:  1975-01-01       Impact factor: 5.858

3.  Differences of cyclophosphamide and 6-mercaptopurine metabolic rates in perfused liver of normal and tumour-bearing animals.

Authors:  I Bartosek; M G Donelli; A Guaitani; T Colombo; R Russo; S Garattini
Journal:  Biochem Pharmacol       Date:  1975-01-15       Impact factor: 5.858

4.  Drug metabolism in tumor-bearing rats. I. Activities of NADPH-linked electron transport and drug-metabolizing enzyme systems in liver microsomes of tumor-bearing rats.

Authors:  R Kato; A Takanaka; A Takahashi; K Onoda
Journal:  Jpn J Pharmacol       Date:  1968-06

5.  Influence of cancer on the levels of pentobarbital in the blood and brain of mice.

Authors:  G C Sharma; S Garb
Journal:  Gan       Date:  1974-12

6.  Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.

Authors:  T A Connors; P J Cox; P B Farmer; A B Foster; M Jarman
Journal:  Biochem Pharmacol       Date:  1974-01-01       Impact factor: 5.858

7.  Clinical pharmacology of cyclophosphamide.

Authors:  C M Bagley; F W Bostick; V T DeVita
Journal:  Cancer Res       Date:  1973-02       Impact factor: 12.701

Review 8.  Cyclophosphamide: use in practice.

Authors:  M E Gershwin; E J Goetzl; A D Steinberg
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

9.  Effect of phenobarbital and SKF 525-A on the teratogenicity of cyclophosphamide in mice.

Authors:  J E Gibson; B A Becker
Journal:  Teratology       Date:  1968-11

10.  Metabolism of cyclophosphamide.

Authors:  N Brock; H J Hohorst
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

View more
  2 in total

1.  Effects of advanced leukemia on hepatic drug-metabolizing activity in the mouse.

Authors:  G Powis; R N Harris; P J Basseches; K S Santone
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  P-aminosalicylate metabolism in cancer patients sensitive and resistant to chemotherapy.

Authors:  J G Lavigne; A Barry; C d'Auteuil; J M Delage
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.